🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07724587
Recruiting Not applicable

The Effectiveness and Safety of Combined Research on Uremic Sarcopenia

NCT07724587 · tracked via the Priya Life Science China tracker
Sponsor
Ningbo Medical Center Lihuili Hospital
Phase
Not applicable
Started
2025-09-01
Last updated
2026-07-24

Condition(s) studied

Sarcopenia

Investigational drug(s) / intervention(s)

Received mindfulness meditation training during dialysis in addition to exercise therapy.

Received mindfulness meditation training during dialysis in addition to exercise therapy.: The SG received pre-dialysis progressive resistance training (PRT), while the IG added mindfulness meditation during dialysis.

Study summary

Objective: To investigate the clinical efficacy and safety of mindfulness meditation during dialysis combined with pre-dialysis progressive resistance training (PRT) for sarcopenia in patients undergoing maintenance hemodialysis (MHD).

Methods: In the randomized controlled trial, 76 MHD patients with sarcopenia were divided into three groups: control group (CG), sports group (SG), and intervention group (IG). All groups received standard dialysis, health education, and dietary guidance. The SG received pre-dialysis PRT, while the IG added mindfulness meditation during dialysis. Efficacy and safety were evaluated at baseline and after 12 weeks. Ultrasound assessments of muscle mass were conducted at baseline, week 4, week 8, and week 12.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Meet the updated Asian diagnostic criteria for sarcopenia * Stable vital signs and general physical condition * Willing and able to cooperate with supervised exercise training * Regular hemodialysis 3 times per week for at least 3 months Exclusion Criteria: * Acute cardiovascular or cerebrovascular events within the previous 3 months * Cognitive dysfunction affecting study cooperation and exercise completion * Severe osteoarticular or limb movement disorders preventing standardized exercise training * Active systemic infection

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Yongyao Wu Ningbo China Recruiting

More Ningbo Medical Center Lihuili Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07724587 on ClinicalTrials.gov ↗ ← All trials in China